Invention Grant
US08399480B2 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
有权
羟甲基吡咯烷作为β3肾上腺素能受体激动剂
- Patent Title: Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
- Patent Title (中): 羟甲基吡咯烷作为β3肾上腺素能受体激动剂
-
Application No.: US12936221Application Date: 2009-04-02
-
Publication No.: US08399480B2Publication Date: 2013-03-19
- Inventor: Richard Berger , Lehua Chang , Scott D. Edmondson , Stephen D. Goble , Sookhee Nicole Ha , Nam Fung Kar , Ihor E. Kopka , Bing Li , Gregori J. Morriello , Chris R. Moyes , Dong-Ming Shen , Liping Wang , Cheng Zhu
- Applicant: Richard Berger , Lehua Chang , Scott D. Edmondson , Stephen D. Goble , Sookhee Nicole Ha , Nam Fung Kar , Ihor E. Kopka , Bing Li , Gregori J. Morriello , Chris R. Moyes , Dong-Ming Shen , Liping Wang , Cheng Zhu
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Patricia A. Shatynski; Valerie J. Camara
- International Application: PCT/US2009/039253 WO 20090402
- International Announcement: WO2009/124167 WO 20091008
- Main IPC: A61K43/90
- IPC: A61K43/90 ; A01K31/44 ; C07D237/00
Abstract:
The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
Public/Granted literature
- US20110028481A1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS Public/Granted day:2011-02-03
Information query
